| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 39.3823 | 5 |
| GSM780708 | Untreated after 4 days (C2_1) | 36.6096 | 1 |
| GSM780709 | Untreated after 4 days (C3_1) | 46.1774 | 33 |
| GSM780719 | Untreated after 4 days (C1_2) | 40.2086 | 7 |
| GSM780720 | Untreated after 4 days (C2_2) | 38.812 | 4 |
| GSM780721 | Untreated after 4 days (C3_2) | 37.428 | 2 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 41.8105 | 12 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 43.3138 | 19 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 44.9324 | 27 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 44.6351 | 25 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 41.9927 | 13 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 40.9542 | 9 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 42.2257 | 14 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 37.4174 | 2 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 40.7591 | 9 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 42.2706 | 14 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 43.2438 | 19 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 45.8719 | 31 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 40.7349 | 9 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 42.5022 | 15 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 39.1756 | 4 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 43.3055 | 19 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 39.6442 | 6 |